Kevin Breen
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Aging top 5%
Papers in
-
- Mitochondrial Function and Pathology 2
- Retinal Development and Disorders 2
- Metabolism, Diabetes, and Cancer 1
-
- Glaucoma and retinal disorders 3
- Retinal Diseases and Treatments 2
- Co-authors
- I. Francis Cheng (2 shared papers)Donald E. Ayer (3 shared papers)Carrie A. Stoltzman (2 shared papers)Alejandra Bosco (4 shared papers)Michael R. Steele (4 shared papers)Monica L. Vetter (4 shared papers)Christopher W. Peterson (1 shared paper)Deborah M. Muoio (1 shared paper)
- Journals
- Experimental Eye Research (1 paper)Science Translational Medicine (1 paper)BioMetals (1 paper)Molecular Therapy (1 paper)Disease Models & Mechanisms (1 paper)
- Partner nations
- United States
In The Last Decade
Kevin Breen
10 papers receiving 914 citations
Peers
Comparison fields: 5 of 89
- Ophthalmology 210
- Aging 40
- Neurology 156
- Biochemistry 75
- Molecular Biology 444
Countries citing papers authored by Kevin Breen
This map shows the geographic impact of Kevin Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Breen more than expected).
Fields of papers citing papers by Kevin Breen
This network shows the impact of papers produced by Kevin Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Breen. The network helps show where Kevin Breen may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Breen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 221 | |
| 2 | 2000 | 190 | |
| 3 | 2015 | 122 | |
| 4 | 2003 | 95 | |
| 5 | 2006 | 94 | |
| 6 | 2018 | 79 | |
| 7 | 2016 | 55 | |
| 8 | 2007 | 35 | |
| 9 | 2016 | 27 | |
| 10 | 2023 | 18 |
About Kevin Breen
Kevin Breen is a scholar working on Molecular Biology, Ophthalmology, Cellular and Molecular Neuroscience, Neurology and Immunology, having authored 10 papers that have together received 936 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Retinal Diseases and Treatments (2 papers), Mitochondrial Function and Pathology (2 papers), Axon Guidance and Neuronal Signaling (2 papers), Retinal Development and Disorders (2 papers), Pancreatic function and diabetes (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Ophthalmology (210 citations), Aging (40 citations), Neurology (156 citations), Biochemistry (75 citations) and Molecular Biology (444 citations). Kevin Breen has collaborated with scholars based in United States. Frequent co-authors include I. Francis Cheng, Donald E. Ayer, Carrie A. Stoltzman, Alejandra Bosco, Michael R. Steele, Monica L. Vetter, Christopher W. Peterson, Deborah M. Muoio, Andrew N. Billin and Cesar O. Romero. Their work appears in journals such as Experimental Eye Research, Science Translational Medicine, BioMetals, Molecular Therapy and Disease Models & Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.